JOAQUÍN
DÍAZ MEDIAVILLA
Ikertzailea 2014-(e)ra arte
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaHospital de la Santa Creu i Sant Pau-ko ikertzaileekin lankidetzan egindako argitalpenak (16)
2013
2012
-
High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma
Blood, Vol. 119, Núm. 3, pp. 687-691
-
Multiparameter flow cytometry evaluation of plasma cell DNA content and proliferation in 595 transplant-eligible patients with myeloma included in the Spanish GEM2000 and GEM2005<65y trials
American Journal of Pathology, Vol. 181, Núm. 5, pp. 1870-1878
-
Study of three families with Hb agrinio [α29(B10)Leu→Pro, CTG>CCG (α2)] in the spanish population: Three homozygous cases
Hemoglobin, Vol. 36, Núm. 6, pp. 526-532
2011
-
Invasive fungal infections in onco-haematology: A spanish perspective
Revista Espanola de Quimioterapia, Vol. 24, Núm. 3, pp. 168-172
-
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance
Blood, Vol. 118, Núm. 17, pp. 4547-4553
2010
-
Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study
Haematologica, Vol. 95, Núm. 11, pp. 1913-1920
-
Utilización de bisfosfonatos en pacientes con mieloma múltiple: recomendaciones del comité de expertos del Grupo Español de Mieloma del Programa Español de Tratamientos en Hematología
Medicina Clinica, Vol. 134, Núm. 6, pp. 268-278
2008
2007
2005
-
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse
Annals of Oncology, Vol. 16, Núm. 4, pp. 625-633
2003
-
Autologous stem cell transplantation for primary refractory Hodgkin's disease: Results and clinical variables affecting outcome
Annals of Oncology, Vol. 14, Núm. 5, pp. 745-751
-
Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia
Haematologica, Vol. 88, Núm. 11, pp. 1213-1220
2001
-
Autologous stem-cell transplantation for Hodgkin's disease: Results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Ósea Spanish Cooperative Group
Journal of Clinical Oncology, Vol. 19, Núm. 5, pp. 1395-1404
1998
-
Autologous peripheral blood stem cell transplantation for multiple myeloma: A report of 259 cases from the Spanish Registry
Bone Marrow Transplantation, Vol. 21, Núm. 2, pp. 133-140
1993
-
Frozen vs. nonfrozen bone marrow for autologous transplantation in lymphomas: A report from the Spanish GEL/TAMO Cooperative Group
Annals of Hematology, Vol. 67, Núm. 3, pp. 111-114